Our team of researchers is a dedicated and diverse team of physicians and allied health professionals with expertise in the treatment of HIV, hepatitis B, and hepatitis C, and Nonalcoholic Steatohepatitis as well as HIV prevention (PrEP). Our research institute has conducted over 100 clinical trials studying the newest therapies available from the leading international biopharmaceutical companies. Our current team includes 4 Sub-Investigators, 1 Clinical Research Director, 4 Clinical Research Coordinators, 3 Clinical Research Associates, and 4 Research Assistants working under the supervision of the Principal Investigator.